Skip to main content
Fig. 5 | Cancer Cell International

Fig. 5

From: As a prognostic biomarker of clear cell renal cell carcinoma RUFY4 predicts immunotherapy responsiveness in a PDL1-related manner

Fig. 5

RUFY4 depletion impaired proliferation rather than migration or invasion of cancer cells. A Relative mRNA levels of RUFY4 in the control cells and RUFY4-knockdown cells. t-test, ****p < 0.0001. B Western blot assay for the protein levels of RUFY4 in indicated cells. C Migration and invasion assay for indicated RCC cells (Magnification: 200×). t-test, p = ns (no significance). D Cell growth curves of CCK8 assays for indicated cells. t-test, ****p < 0.0001

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us